Xueshibojie Liu

Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation

Xingkai Liu, Tuo Wang, Xueshibojie Liu et al. · International Immunopharmacology · 2016 · 106 citations

Life Sciences, Immunology, Pharmacology +16

Facile synthesis of CDs@ZIF-8 nanocomposites as excellent peroxidase mimics for colorimetric detection of H2O2 and glutathione

Yufei Wang, Xueshibojie Liu, Mengke Wang et al. · Sensors and Actuators B Chemical · 2020 · 99 citations · Full text

Natural Sciences, Chemistry, Materials Science +16

Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-κB Signaling Pathways

Duo Yu, Xueshibojie Liu, Guangxin Zhang et al. · Frontiers in Pharmacology · 2018 · 89 citations · Full text

Medicine, Pharmacology, Toxicology +17

A dual responsive targeted drug delivery system based on smart polymer coated mesoporous silica for laryngeal carcinoma treatment

Xueshibojie Liu, Dan Yu, Chunshun Jin et al. · New Journal of Chemistry · 2014 · 65 citations

Pharmacy, Pharmaceutics, Pharmacology +17

The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation

Dan Yu, Xueshibojie Liu, Guanghong Han et al. · Cell Communication and Signaling · 2019 · 61 citations · Full text

Medicine, Immunology, Oncology +14